A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus

NCT03407118 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: LY900014
DRUG: Insulin Lispro

Sponsor

Eli Lilly and Company